Jennifer Szatkowski, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 262-825-8509 |
Dr. Anna S Masters, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-7401 |
Vinay Setty, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-7401 Fax: 402-232-9398 |
Dr. Anthony Charles Eschliman, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-595-2275 Fax: 402-595-1970 |
Dr. Ashley Louise Sawtelle, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-7401 |
Samantha Brenner, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-7401 Fax: 402-232-9398 |
News Archive
Does Parkinson's disease start in the brain or the gut? In a new contribution published in the Journal of Parkinson's Disease, scientists hypothesize that PD can be divided into two subtypes: gut-first, originating in the peripheral nervous system of the gut and spreading to the brain; and brain-first, originating in the brain, or entering the brain via the olfactory system, and spreading to the brainstem and peripheral nervous system.
Paying doctors financial rewards to meet targets for improving the care of patients made no discernible difference to the health or treatment of people with high blood pressure, a study has found.
Among full-term newborns with moderate or severe hypoxic ischemic encephalopathy (damage to cells in the central nervous system from inadequate oxygen), receiving deeper or longer duration cooling did not reduce risk of neonatal intensive care unit death, compared to usual care, according to a study in the December 24/31 issue of JAMA.
Life Technologies Corporation (NASDAQ:LIFE) today announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation (NYSE:DHR) for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies' joint venture partner in the mass spectrometry business, MDS Analytical Technologies, a division of MDS Inc. (NYSE:MDZ). The transaction is expected to close in the fourth quarter of 2009.
› Verified 8 days ago